Cynthia Collins Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cynthia Collins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cynthia Collins. Cynthia Collins is Group Vice President in BECKMAN COULTER INC ($BEC) and CEO in Editas Medicine, Inc. ($EDIT) and Director in Editas Medicine, Inc. ($EDIT) and Interim CEO in Editas Medicine, Inc. ($EDIT) and Director in DermTech, Inc. ($CNACU).
Latest Insider Trading Transactions of Cynthia Collins
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BEC, DMTK, EDIT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 66.65 | 1,262 | 84,112 | 43,760 | 45 K to 43.8 K (-2.80 %) |
| Aug 21 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 36.66 | 1,976 | 72,440 | 45,022 | 47 K to 45 K (-4.20 %) |
| Jun 19 2020 | DMTK | DermTech, Inc. | Collins Cynthia | Director | Grant | A | 0.00 | 8,000 | 0 | 33,483 | 25.5 K to 33.5 K (+31.39 %) |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 28.05 | 93,750 | 2,629,688 | 93,750 | |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 15,625 | 0 | 46,998 | 31.4 K to 47 K (+49.80 %) |
| Feb 03 2020 | CNACU | DermTech, Inc. | Collins Cynthia | Director | Grant | A | 0.00 | 6,000 | 0 | 25,483 | 19.5 K to 25.5 K (+30.80 %) |
| Jan 03 2020 | CNACU | DermTech, Inc. | Collins Cynthia | Director | Option Exercise | M | 0.00 | 8,755 | 0 | 0 | |
| Jan 03 2020 | CNACU | DermTech, Inc. | Collins Cynthia | Director | Buy | M | 0.00 | 8,755 | 0 | 19,483 | 10.7 K to 19.5 K (+81.61 %) |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 26.57 | 250,000 | 6,642,500 | 250,000 | |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 26.57 | 500,000 | 13,285,000 | 500,000 | |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 20,000 | 0 | 31,373 | 11.4 K to 31.4 K (+175.86 %) |
| Aug 21 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 25.83 | 5,193 | 134,135 | 11,373 | 16.6 K to 11.4 K (-31.35 %) |
| Aug 21 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 8,283 | 0 | 16,566 | 8.3 K to 16.6 K (+100.00 %) |
| Aug 07 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 8,283 | 0 | 16,566 | 8.3 K to 16.6 K (+100.00 %) |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | Interim CEO | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Feb 04 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | Director | Option Exercise | A | 0.00 | 8,283 | 0 | 8,283 | |
| Dec 10 2018 | EDIT | Editas Medicine, I ... | Collins Cynthia | Director | Option Exercise | A | 29.69 | 23,076 | 685,126 | 23,076 | |
| Feb 08 2008 | BEC | BECKMAN COULTER IN ... | Collins Cynthia | Group Vice Presiden ... | Grant | A | 0.00 | 2,400 | 0 | 9,800 | 7.4 K to 9.8 K (+32.43 %) |
| Jan 04 2008 | BEC | BECKMAN COULTER IN ... | Collins Cynthia | Group Vice Presiden ... | Option Exercise | A | 72.49 | 9,600 | 695,904 | 9,600 | |
| Jan 04 2008 | BEC | BECKMAN COULTER IN ... | Collins Cynthia | Group Vice Presiden ... | Grant | A | 0.00 | 2,400 | 0 | 7,400 | 5 K to 7.4 K (+48.00 %) |
Page: 1